MK0686 in Postsurgery Dental Pain (0686-002)

To compare the pain relieving effect of MK0686 to placebo or ibuprofen after dental surgery.

Completed

Looking for future studies?

Key information

Conditions

Pain, Postoperative Neurologic Manifestations Pain Pathologic Processes Pathological Conditions, Signs and Symptoms Postoperative Complications Signs and Symptoms

Age range

18 year–45 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Men and women ages 18-45 years who are scheduled to have 2 or more third molars (wisdom teeth) removed
Patients must agree to remain in the clinic for 24 hours after surgery

Exclusion criteria

Patient has history of heart disease, asthma, pulmonary disease
Patient must discontinue use of certain pain medicines 24-72 hours prior to the surgery

Treatment and study plan

MK0686

Drug

Sponsors and collaborators

Lead sponsor

Merck Sharp & Dohme LLC

Industry

Registry information

Important dates

Study start: 2004
Primary completion: 2004
Study completion: 2004
First posted: Sep 21, 2007
Registry last updated: Jun 26, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed